Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #226329 on Elite Pharmaceuticals Inc (ELTP)
Couch
09/06/16 8:01 PM
#226338 RE: vanwes1 #226329
The total approval rate jumped nearly 20% to 74.6% after companies submitted responses to the US Food and Drug Administration's (FDA) CRLs. A third round of responses brought that percentage up an additional 8.3% to 82.9% - See more at: http://www.raps.org/focus-online/news/news-article-view/article/1138/bio-analysis-resubmissions-after-third-round-of-fda-review-not-worth-the-effort.aspx#sthash.sgdvIn7N.dpuf
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads